Home > Healthcare > Healthcare IT > Healthcare Outsourcing > Infection Control Surveillance Solutions Market
With respect to the component, the infection control surveillance solutions market is bifurcated into software and services. The software segment held more than USD 370 million in revenue in 2021 and is anticipated to follow a positive growth trajectory between 2022 and 2030. The segmental expansion can be credited to the emergence of several healthcare-associated infections and subsequent growth in demand for infection control software. According to the Office of Disease Prevention and Health Promotion, 1 out of every 25 hospitalized patients at any given time in the United States are affected by a healthcare-associated infection. This software help analyzes and shares real-time data and provides feedback that helps medical teams and staff mitigate and control infections more effectively, which will boost its adoption in the forthcoming years.
Based on end-use, the infection control surveillance solutions market is categorized into hospitals, clinics, ambulatory surgical centers, and specialty centers. The hospital segment accounted for more than 67% of the industry share in 2021 and is poised to register significant progress during the assessment period. The increasing burden of infectious and chronic health disorders has resulted in a growing number of people requiring frequent hospitalizations, leading to a considerable rise in hospital-acquired infections and associated healthcare expenditure. This has boosted the demand for better healthcare infrastructure resulting in the construction of new hospitals and healthcare facilities, strengthening the industry outlook.
The North America infection control surveillance solutions market constituted over 44% of the revenue share in 2021 and is likely to experience further expansion in the foreseeable future. The region has registered a noticeable rise in disposable incomes and a significant improvement in economic growth. In addition, the rising healthcare concerns have significantly pushed the healthcare expenditure across the region. North America houses several industry participants that have been focusing on introducing better and advanced products in the market, creating a pool of opportunities for the regional industry.